Literature DB >> 11559048

Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity.

K D Sugden1, C K Campo, B D Martin.   

Abstract

Intracellular reductive activation of the human carcinogen chromate, Cr(VI), is a necessary step in the formation of DNA lesions that lead to cancer. Reductive activation forms the transient metastable high-valent oxidation state of Cr(V) as a precursor to the final intracellularly stable oxidation state, Cr(III). In this study, we have used a model high-valent Cr(V) complex, N,N'-ethylenebis(salicylideneanimato)oxochromium(V), Cr(V)-Salen, to probe the mechanism of interaction between this oxidation state of chromium and DNA. This interaction was found to be specific toward the oxidation of the nucleic acid base guanine in unmodified single- and double-stranded oligonucleotides as measured by an increased level of DNA strand cleavage at these sites following piperidine treatment. Replacement of a single guanine residue in DNA with a more readily oxidized 7,8-dihydro-8-oxoguanine (8-oxo-G) base allowed for site-specific oxidation at this modified site within the DNA strand by the Cr(V)-Salen complex. HPLC and ESI-mass spectrometry were used to identify the modified guanine base lesions formed in the reaction of this high-valent chromium complex with the 8-oxo-G-containing DNA substrate. Two of these modified base lesions, identified as guanidinohydantoin and spiroiminodihydantoin, were found in the reaction of the Cr(V)-Salen complex with 8-oxo-G-modified DNA, while only one, spiroiminodihydantoin, was formed from oxidation of the 8-oxo-G nucleoside. A primer extension assay using the exo(-) Klenow fragment demonstrated polymerase arrest at the site of these base modifications as well as a high degree of misincorporation of adenine opposite the site of modification. These results suggest that mutations arising from G --> T transversions would predominate with these lesions. The mechanism of damage and base oxidation products for the interaction between high-valent chromium and DNA described herein may be relevant to the in vivo formation of DNA damage leading to cancer in chromate-exposed human populations. These results also suggest how high-valent chromium can act as a cocarcinogen with 8-oxo-G-forming xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559048     DOI: 10.1021/tx010088+

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  53 in total

1.  pH-Dependent Equilibrium between 5-Guanidinohydantoin and Iminoallantoin Affects Nucleotide Insertion Opposite the DNA Lesion.

Authors:  Judy Zhu; Aaron M Fleming; Anita M Orendt; Cynthia J Burrows
Journal:  J Org Chem       Date:  2015-11-24       Impact factor: 4.354

2.  Guanine oxidation product 5-carboxamido-5-formamido-2-iminohydantoin induces mutations when bypassed by DNA polymerases and is a substrate for base excision repair.

Authors:  Omar R Alshykhly; Aaron M Fleming; Cynthia J Burrows
Journal:  Chem Res Toxicol       Date:  2015-09-02       Impact factor: 3.739

3.  Chemical and electrochemical oxidation of C8-arylamine adducts of 2'-deoxyguanosine.

Authors:  James S Stover; Madalina Ciobanu; David E Cliffel; Carmelo J Rizzo
Journal:  J Am Chem Soc       Date:  2007-01-26       Impact factor: 15.419

4.  DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis.

Authors:  Travis J O'Brien; Preston Witcher; Bradford Brooks; Steven R Patierno
Journal:  Mutat Res       Date:  2009-02-06       Impact factor: 2.433

Review 5.  Removal of oxidatively generated DNA damage by overlapping repair pathways.

Authors:  Vladimir Shafirovich; Nicholas E Geacintov
Journal:  Free Radic Biol Med       Date:  2016-11-04       Impact factor: 7.376

6.  G-quadruplex folds of the human telomere sequence alter the site reactivity and reaction pathway of guanine oxidation compared to duplex DNA.

Authors:  Aaron M Fleming; Cynthia J Burrows
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

7.  FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.

Authors:  Susan K Vilcheck; Susan Ceryak; Travis J O'Brien; Steven R Patierno
Journal:  Mutat Res       Date:  2006-08-08       Impact factor: 2.433

8.  The Nonbulky DNA Lesions Spiroiminodihydantoin and 5-Guanidinohydantoin Significantly Block Human RNA Polymerase II Elongation in Vitro.

Authors:  Marina Kolbanovskiy; Moinuddin A Chowdhury; Aditi Nadkarni; Suse Broyde; Nicholas E Geacintov; David A Scicchitano; Vladimir Shafirovich
Journal:  Biochemistry       Date:  2017-06-07       Impact factor: 3.162

9.  Influence of substrate complexity on the diastereoselective formation of spiroiminodihydantoin and guanidinohydantoin from chromate oxidation.

Authors:  Julia N Gremaud; Brooke D Martin; Kent D Sugden
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

10.  Structural context effects in the oxidation of 8-oxo-7,8-dihydro-2'-deoxyguanosine to hydantoin products: electrostatics, base stacking, and base pairing.

Authors:  Aaron M Fleming; James G Muller; Adrienne C Dlouhy; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2012-08-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.